Rowley SD - Search Results

1

Phase I study of combination drug purging for autologous bone marrow transplantation.

Rowley SD, Miller CB, Piantadosi S, Davis JM, Santos GW, Jones RJ. Rowley SD, et al. J Clin Oncol. 1991 Dec;9(12):2210-8. doi: 10.1200/JCO.1991.9.12.2210. J Clin Oncol. 1991. PMID: 1960561 Clinical Trial.

2

Purging with 4-hydroperoxycyclophosphamide combinations.

Jones RJ, Miller CB, Rowley SD. Jones RJ, et al. Among authors: rowley sd. Prog Clin Biol Res. 1992;377:1-9; discussion 10-1. Prog Clin Biol Res. 1992. PMID: 1438406 No abstract available.

3

Incidence of bacterial contamination of bone marrow grafts.

Schepers KG, Davis JM, Rowley SD. Schepers KG, et al. Among authors: rowley sd. Prog Clin Biol Res. 1992;377:379-84. Prog Clin Biol Res. 1992. PMID: 1438434 No abstract available.

4

Selection of normal human hematopoietic stem cells for bone marrow transplantation using immunomagnetic microspheres and CD34 antibody.

Strauss LC, Trischmann TM, Rowley SD, Wiley JM, Civin CI. Strauss LC, et al. Among authors: rowley sd. Am J Pediatr Hematol Oncol. 1991 Summer;13(2):217-21. doi: 10.1097/00043426-199122000-00018. Am J Pediatr Hematol Oncol. 1991. PMID: 1712550

5

Correlation of occult clonogenic leukemia drug sensitivity with relapse after autologous bone marrow transplantation.

Miller CB, Zehnbauer BA, Piantadosi S, Rowley SD, Jones RJ. Miller CB, et al. Among authors: rowley sd. Blood. 1991 Aug 15;78(4):1125-31. Blood. 1991. PMID: 1868244 Free article.

6

High-dose chemotherapy with reinfusion of purged autologous bone marrow following dose-intense induction as initial therapy for metastatic breast cancer.

Kennedy MJ, Beveridge RA, Rowley SD, Gordon GB, Abeloff MD, Davidson NE. Kennedy MJ, et al. Among authors: rowley sd. J Natl Cancer Inst. 1991 Jul 3;83(13):920-6. doi: 10.1093/jnci/83.13.920. J Natl Cancer Inst. 1991. PMID: 1906111 Clinical Trial.

7

Analysis of factors predicting speed of hematologic recovery after transplantation with 4-hydroperoxycyclophosphamide-purged autologous bone marrow grafts.

Rowley SD, Piantadosi S, Marcellus DC, Jones RJ, Davidson NE, Davis JM, Kennedy J, Wiley JM, Wingard JR, Yeager AM, et al. Rowley SD, et al. Bone Marrow Transplant. 1991 Mar;7(3):183-91. Bone Marrow Transplant. 1991. PMID: 2059755

8

Using elutriation to engineer bone marrow allografts.

Noga SJ, Wagner JE, Rowley SD, Davis JM, Vogelsang GB, Hess AD, Saral R, Santos GW, Donnenberg AD. Noga SJ, et al. Among authors: rowley sd. Prog Clin Biol Res. 1990;333:345-59; discussion 360-1. Prog Clin Biol Res. 1990. PMID: 2137932 Clinical Trial.

9

Ex vivo chemopurging of autologous bone marrow with 4-hydroperoxycyclophosphamide to eliminate occult leukemic cells. Laboratory and clinical observations.

Yeager AM, Rowley SD, Kaizer H, Santos GW. Yeager AM, et al. Among authors: rowley sd. Am J Pediatr Hematol Oncol. 1990 Fall;12(3):245-56. doi: 10.1097/00043426-199023000-00001. Am J Pediatr Hematol Oncol. 1990. PMID: 2240470 Review.

10

Density-gradient separation of autologous bone marrow grafts before ex vivo purging with 4-hydroperoxycyclophosphamide.

Rowley SD, Davis JM, Piantadosi S, Jones RJ, Yeager AM, Santos GW. Rowley SD, et al. Bone Marrow Transplant. 1990 Nov;6(5):321-7. Bone Marrow Transplant. 1990. PMID: 2291993 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

180 results

Search Page

Filters